Related references
Note: Only part of the references are listed.Sepsis induces interleukin 6, gp130/JAK2/STAT3, and muscle wasting
Lukas Zanders et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2022)
A prospective clinical study on the mechanisms underlying critical illness myopathy-A time-course approach
Nicola Cacciani et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2022)
TGFβ signalling acts as a molecular brake of myoblast fusion
Julie Melendez et al.
NATURE COMMUNICATIONS (2021)
TGFβ signaling curbs cell fusion and muscle regeneration
Francesco Girardi et al.
NATURE COMMUNICATIONS (2021)
Potential Targets to Mitigate Trauma- or Sepsis-Induced Immune Suppression
Christian B. Bergmann et al.
FRONTIERS IN IMMUNOLOGY (2021)
Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2021
Stephan von Haehling et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2021)
Serum amyloid A1 mediates myotube atrophy via Toll-like receptors
Alexander Hahn et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2020)
The regulatory role of Myomaker and Myomixer-Myomerger-Minion in muscle development and regeneration
Bide Chen et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2020)
Single-cell transcriptomics of 20 mouse organs creates a Tabula Muris
Nicholas Schaum et al.
NATURE (2018)
Non-Smad Signaling Pathways of the TGF-β Family
Ying E. Zhang
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2017)
Function of the myogenic regulatory factors Myf5, MyoD, Myogenin and MRF4 in skeletal muscle, satellite cells and regenerative myogenesis
Peter S. Zammit
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2017)
Myomerger induces fusion of non-fusogenic cells and is required for skeletal muscle development
Malgorzata E. Quinn et al.
NATURE COMMUNICATIONS (2017)
Secreted Frizzled-Related Protein 2 and Inflammation-Induced Skeletal Muscle Atrophy
Xiaoxi Zhu et al.
CRITICAL CARE MEDICINE (2017)
Deletion of Nlrp3 protects from inflammation-induced skeletal muscle atrophy
Nora Huang et al.
INTENSIVE CARE MEDICINE EXPERIMENTAL (2017)
Mechanisms of Chronic Muscle Wasting and Dysfunction after an Intensive Care Unit Stay
Claudia dos Santos et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
Transcriptomic analysis reveals abnormal muscle repair and remodeling in survivors of critical illness with sustained weakness
Christopher J. Walsh et al.
SCIENTIFIC REPORTS (2016)
SPSB1, a Novel Negative Regulator of the Transforming Growth Factor-β Signaling Pathway Targeting the Type II Receptor
Sheng Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Sepsis induces long-term metabolic and mitochondrial muscle stem cell dysfunction amenable by mesenchymal stem cell therapy
P. Rocheteau et al.
NATURE COMMUNICATIONS (2015)
Developmental myosins: expression patterns and functional significance
Stefano Schiaffino et al.
SKELETAL MUSCLE (2015)
Dynamics of myosin degradation in intensive care unit-acquired weakness during severe critical illness
Tobias Wollersheim et al.
INTENSIVE CARE MEDICINE (2014)
Myomaker is a membrane activator of myoblast fusion and muscle formation
Douglas P. Millay et al.
NATURE (2013)
Small Molecule-Mediated TGF-β Type II Receptor Degradation Promotes Cardiomyogenesis in Embryonic Stem Cells
Erik Willems et al.
CELL STEM CELL (2012)
Satellite cells are essential for skeletal muscle regeneration: the cell on the edge returns centre stage
Frederic Relaix et al.
DEVELOPMENT (2012)
Smad3 signaling is required for satellite cell function and myogenic differentiation of myoblasts
Xiaojia Ge et al.
CELL RESEARCH (2011)
Regulation of Inducible Nitric-oxide Synthase by the SPRY Domain- and SOCS Box-containing Proteins
Tadashi Nishiya et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Functional Disability 5 Years after Acute Respiratory Distress Syndrome
Margaret S. Herridge et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
A framework for diagnosing and classifying intensive care unit-acquired weakness
Robert D. Stevens et al.
CRITICAL CARE MEDICINE (2010)
Structural Basis for Par-4 Recognition by the SPRY Domain- and SOCS Box-Containing Proteins SPSB1, SPSB2, and SPSB4
Panagis Filippakopoulos et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
Acquired weakness, handgrip strength, and mortality in critically ill patients
Naeem A. Ali et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Smad7 promotes and enhances skeletal muscle differentiation
Helen D. Kollias et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
MyoD and the transcriptional control of myogenesis
CA Berkes et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2005)
The SPRY domain-containing SOCS box protein 1 (SSB-1) interacts with MET and enhances the hepatocyte growth factor-induced Erk-Elk-1-serum response element pathway
DK Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Mechanisms of TGF-β signaling from cell membrane to the nucleus
YG Shi et al.
CELL (2003)
TGF-β inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3
D Liu et al.
GENES & DEVELOPMENT (2001)
Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo
SC Bodine et al.
NATURE CELL BIOLOGY (2001)
The insulin-like growth factor-phosphatidylinositol 3-kinase-Akt signaling pathway regulates myogenin expression in normal myogenic cells but not in Rhabdomyosarcoma-derived RD cells
Q Xu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)